These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Sequences located 3' to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A gamma-globin gene in transgenic mice. Anagnou NP, Perez-Stable C, Gelinas R, Costantini F, Liapaki K, Constantopoulou M, Kosteas T, Moschonas NK, Stamatoyannopoulos G. J Biol Chem; 1995 Apr 28; 270(17):10256-63. PubMed ID: 7537267 [Abstract] [Full Text] [Related]
30. The Australian type of nondeletional G gamma-HPFH has a C-->G substitution at nucleotide -114 of the G gamma gene. Motum PI, Deng ZM, Huong L, Trent RJ. Br J Haematol; 1994 Jan 28; 86(1):219-21. PubMed ID: 7516698 [Abstract] [Full Text] [Related]
31. A fetal globin gene mutation in A gamma nondeletion hereditary persistence of fetal hemoglobin increases promoter strength in a nonerythroid cell. Rixon MW, Gelinas RE. Mol Cell Biol; 1988 Feb 28; 8(2):713-21. PubMed ID: 2451123 [Abstract] [Full Text] [Related]
32. An embryonic/fetal beta-type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer. Tanabe O, Katsuoka F, Campbell AD, Song W, Yamamoto M, Tanimoto K, Engel JD. EMBO J; 2002 Jul 01; 21(13):3434-42. PubMed ID: 12093744 [Abstract] [Full Text] [Related]
33. Sardinian G gamma-HPFH: a T----C substitution in a conserved "octamer" sequence in the G gamma-globin promoter. Ottolenghi S, Nicolis S, Taramelli R, Malgaretti N, Mantovani R, Comi P, Giglioni B, Longinotti M, Dore F, Oggiano L. Blood; 1988 Mar 01; 71(3):815-7. PubMed ID: 2449927 [Abstract] [Full Text] [Related]
34. A role for the distal CCAAT box of the gamma-globin gene in Hb switching. Katsube T, Fukumaki Y. J Biochem; 1995 Jan 01; 117(1):68-76. PubMed ID: 7539789 [Abstract] [Full Text] [Related]
35. Developmental regulation of human gamma- and beta-globin genes in the absence of the locus control region. Starck J, Sarkar R, Romana M, Bhargava A, Scarpa AL, Tanaka M, Chamberlain JW, Weissman SM, Forget BG. Blood; 1994 Sep 01; 84(5):1656-65. PubMed ID: 7520781 [Abstract] [Full Text] [Related]
36. Sequence analysis of the gamma-globin gene locus from a patient with the deletion form of hereditary persistence of fetal hemoglobin. Stolle CA, Penny LA, Ivory S, Forget BG, Benz EJ. Blood; 1990 Jan 15; 75(2):499-504. PubMed ID: 1688505 [Abstract] [Full Text] [Related]
37. Factor binding to the human gamma-globin gene distal CCAAT site: candidates for repression of the normal gene or activation of HPFH mutants. Partington GA, Patient RK. Br J Haematol; 1998 Sep 15; 102(4):940-51. PubMed ID: 9734644 [Abstract] [Full Text] [Related]
38. The upstream region of the human gamma-globin gene promoter. Identification and functional analysis of nuclear protein binding sites. McDonagh KT, Lin HJ, Lowrey CH, Bodine DM, Nienhuis AW. J Biol Chem; 1991 Jun 25; 266(18):11965-74. PubMed ID: 2050690 [Abstract] [Full Text] [Related]
39. High levels of human gamma-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin. Arcasoy MO, Romana M, Fabry ME, Skarpidi E, Nagel RL, Forget BG. Mol Cell Biol; 1997 Apr 25; 17(4):2076-89. PubMed ID: 9121456 [Abstract] [Full Text] [Related]
40. The molecular basis of HPFH in a British family identified by heteroduplex formation. Craig JE, Sheerin SM, Barnetson R, Thein SL. Br J Haematol; 1993 May 25; 84(1):106-10. PubMed ID: 7687855 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]